187 related articles for article (PubMed ID: 19672862)
1. Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis.
Haughian JM; Reno EM; Thorne AM; Bradford AP
Int J Cancer; 2009 Dec; 125(11):2556-64. PubMed ID: 19672862
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta.
Haughian JM; Jackson TA; Koterwas DM; Bradford AP
Endocr Relat Cancer; 2006 Dec; 13(4):1251-67. PubMed ID: 17158769
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium.
Hsu AH; Lum MA; Shim KS; Frederick PJ; Morrison CD; Chen B; Lele SM; Sheinin YM; Daikoku T; Dey SK; Leone G; Black AR; Black JD
Cell Rep; 2018 Jul; 24(3):655-669. PubMed ID: 30021163
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells.
Haughian JM; Bradford AP
J Cell Physiol; 2009 Jul; 220(1):112-8. PubMed ID: 19235902
[TBL] [Abstract][Full Text] [Related]
5. Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21
Zhou Y; Wang K; Zhen S; Wang R; Luo W
Taiwan J Obstet Gynecol; 2016 Dec; 55(6):847-851. PubMed ID: 28040131
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
7. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells.
Zhu X; Kwon CH; Schlosshauer PW; Ellenson LH; Baker SJ
Cancer Res; 2001 Jun; 61(11):4569-75. PubMed ID: 11389092
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide inhibits abnormal proliferation of lymphocytes via AKT/GSK3β signal pathway in systemic lupus erythematosus patients.
Han Y; Zeng F; Tan G; Yang C; Tang H; Luo Y; Feng J; Xiong H; Guo Q
Cell Physiol Biochem; 2013; 31(6):795-804. PubMed ID: 23735868
[TBL] [Abstract][Full Text] [Related]
10. p27 Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells.
Wang Q; Zhou Y; Wang X; Evers BM
Cell Death Differ; 2008 May; 15(5):908-19. PubMed ID: 18408738
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation.
Rössig L; Badorff C; Holzmann Y; Zeiher AM; Dimmeler S
J Biol Chem; 2002 Mar; 277(12):9684-9. PubMed ID: 11779850
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C regulates human pluripotent stem cell self-renewal.
Kinehara M; Kawamura S; Tateyama D; Suga M; Matsumura H; Mimura S; Hirayama N; Hirata M; Uchio-Yamada K; Kohara A; Yanagihara K; Furue MK
PLoS One; 2013; 8(1):e54122. PubMed ID: 23349801
[TBL] [Abstract][Full Text] [Related]
13. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27.
An HJ; Lee YH; Cho NH; Shim JY; Kim JY; Lee C; Kim SJ
Histopathology; 2002 Nov; 41(5):437-45. PubMed ID: 12405911
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
15. ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.
Tong JS; Zhang QH; Wang ZB; Li S; Yang CR; Fu XQ; Hou Y; Wang ZY; Sheng J; Sun QY
PLoS One; 2010 Nov; 5(11):e15408. PubMed ID: 21079811
[TBL] [Abstract][Full Text] [Related]
16. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
[TBL] [Abstract][Full Text] [Related]
17. Molecular determinants of Akt-induced keratinocyte transformation.
Segrelles C; Moral M; Lara MF; Ruiz S; Santos M; Leis H; García-Escudero R; Martínez-Cruz AB; Martínez-Palacio J; Hernández P; Ballestín C; Paramio JM
Oncogene; 2006 Feb; 25(8):1174-85. PubMed ID: 16247457
[TBL] [Abstract][Full Text] [Related]
18. Expression of PTEN, p27, p21 and AKT mRNA and protein in human BEL-7402 hepatocarcinoma cells in transplanted tumors of nude mice treated with the tripeptide tyroservatide (YSV).
Zhu Z; Jia J; Lu R; Lu Y; Fu Z; Zhao L; Wang L; Jin M; Zhao L; Gao W; Yao Z
Int J Cancer; 2006 Mar; 118(6):1539-44. PubMed ID: 16184552
[TBL] [Abstract][Full Text] [Related]
19. RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback through reduced cytosolic p21 and p27.
Hsu YH; Chang CC; Yang NJ; Lee YH; Juan SH
J Cell Physiol; 2014 Oct; 229(10):1455-65. PubMed ID: 24535918
[TBL] [Abstract][Full Text] [Related]
20. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
Zhuo Z; Yu H
Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]